BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 18408223)

  • 1. Survival and reproductive function of 52 women treated with surgery and bleomycin, etoposide, cisplatin (BEP) chemotherapy for ovarian yolk sac tumor.
    de La Motte Rouge T; Pautier P; Duvillard P; Rey A; Morice P; Haie-Meder C; Kerbrat P; Culine S; Troalen F; Lhommé C
    Ann Oncol; 2008 Aug; 19(8):1435-1441. PubMed ID: 18408223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of standard-dose BEP regimen (bleomycin+etoposide+cisplatin) is essential for treatment of ovarian yolk sac tumour.
    Satoh T; Aoki Y; Kasamatsu T; Ochiai K; Takano M; Watanabe Y; Kikkawa F; Takeshima N; Hatae M; Yokota H; Saito T; Yaegashi N; Kobayashi H; Baba T; Kodama S; Saito T; Sakuragi N; Sumi T; Kamura T; Yoshikawa H
    Eur J Cancer; 2015 Feb; 51(3):340-51. PubMed ID: 25559616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
    Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
    Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant Bleomycin, Etoposide, and Cisplatin (BEP) Chemotherapy in the Treatment of Extensively Advanced Yolk Sac Tumors: A Single Center Experience.
    Zhang GY; Zhang R; Wu LY; Li B; Li SM
    Int J Gynecol Cancer; 2018 May; 28(4):713-720. PubMed ID: 29461339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin-induced pulmonary fibrosis after tumor lysis syndrome in a case of advanced yolk sac tumor treated with bleomycin, etoposide and cisplatin (BEP) chemotherapy.
    Doi M; Okamoto Y; Yamauchi M; Naitou H; Shinozaki K
    Int J Clin Oncol; 2012 Oct; 17(5):528-31. PubMed ID: 22127348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pregnancy outcome after prenatal exposure to bleomycin, etoposide and cisplatin for malignant ovarian germ cell tumors: report of 2 cases.
    Han JY; Nava-Ocampo AA; Kim TJ; Shim JU; Park CT
    Reprod Toxicol; 2005; 19(4):557-61. PubMed ID: 15749271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yolk sac tumours of the ovary: evaluation of clinicopathological features and prognostic factors.
    Cicin I; Saip P; Guney N; Eralp Y; Ayan I; Kebudi R; Topuz E
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):210-4. PubMed ID: 19419810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endodermal sinus tumor in pregnancy.
    Malhotra N; Sood M
    Gynecol Oncol; 2000 Aug; 78(2):265-6. PubMed ID: 10926819
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic evaluation of cisplatin, etoposide, and bleomycin chemotherapy regimen in high-risk gestational trophoblastic neoplasia].
    Song SQ; Zhang GN
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug; 47(8):571-6. PubMed ID: 23141175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The activity of taxanes compared with bleomycin, etoposide, and cisplatin in the treatment of sex cord-stromal ovarian tumors.
    Brown J; Shvartsman HS; Deavers MT; Ramondetta LM; Burke TW; Munsell MF; Gershenson DM
    Gynecol Oncol; 2005 May; 97(2):489-96. PubMed ID: 15863149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
    Chu R; Liu P; Chen J; Cheng X; Li K; Che Y; Wang J; Li L; Zhang X; Yao S; Song L; Zhao Y; Huang C; Xue Y; Pan X; Li J; Chen Z; Jiang J; Kong B; Song K
    J Gynecol Oncol; 2023 Mar; 34(2):e12. PubMed ID: 36890292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of patients with yolk sac tumors of the ovary.
    Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
    Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual tumor after the salvage surgery is the major risk factors for primary treatment failure in malignant ovarian germ cell tumors: a retrospective study of single institution.
    Lee CW; Song MJ; Park ST; Ki EY; Lee SJ; Lee KH; Ryu KS; Park JS; Hur SY
    World J Surg Oncol; 2011 Oct; 9():123. PubMed ID: 21988930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: a Taiwanese Gynecologic Oncology Group study.
    Chen CA; Lin H; Weng CS; Wen KC; Lu CH; Chou HH; Huang YF; Kang CY; Ho CM; Yu MH; Chou CY
    Eur J Cancer; 2014 Dec; 50(18):3161-7. PubMed ID: 25459394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center.
    Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD
    Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.
    Tangir J; Zelterman D; Ma W; Schwartz PE
    Obstet Gynecol; 2003 Feb; 101(2):251-7. PubMed ID: 12576247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of non-testicular germ cell tumors in children and adolescents with BEP and VIP: initial results of the MAKEI 89 therapy study].
    Göbel U; Bamberg M; Engert J; Gnekow AK; Haas HJ; Jürgens H; Kühl J; Lenard HG; Lumenta C; Niethammer D
    Klin Padiatr; 1991; 203(4):236-45. PubMed ID: 1719267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
    Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
    Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of malignant ovarian germ cell tumors with preservation of fertility: reproductive performance after persistent remission.
    Kanazawa K; Suzuki T; Sakumoto K
    Am J Clin Oncol; 2000 Jun; 23(3):244-8. PubMed ID: 10857886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservative treatment and long-term follow up of endodermal sinus tumor of the vagina.
    Tao T; Yang J; Cao D; Guo L; Chen J; Lang J; Shen K
    Gynecol Oncol; 2012 May; 125(2):358-61. PubMed ID: 22178761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.